(Total Views: 132)
Posted On: 01/25/2017 5:38:57 AM
Post# of 103055
$CBIS Under the terms of agreement, the company will get research expertise from Dana Farber/Harvard Cancer Center, which will allow the company in development of preclinical and clinical cannabinoid compounds.
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
